Puma Biotechnology Correlations
| PBYI Stock | USD 7.60 0.08 1.04% |
The current 90-days correlation between Puma Biotechnology and Eledon Pharmaceuticals is -0.16 (i.e., Good diversification). The correlation of Puma Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Puma Biotechnology Correlation With Market
Very poor diversification
The correlation between Puma Biotechnology and DJI is 0.83 (i.e., Very poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Puma Stock
| 0.81 | GXEA | Galapagos NV | PairCorr |
| 0.71 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.78 | EQ | Equillium | PairCorr |
| 0.71 | VALN | Valneva SE ADR | PairCorr |
| 0.68 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.84 | 6C1 | CytomX Therapeutics Earnings Call This Week | PairCorr |
| 0.93 | DRTS | Alpha Tau Medical Earnings Call This Week | PairCorr |
| 0.73 | DSGN | Design Therapeutics | PairCorr |
| 0.87 | 0P6S | Bayer AG NA Earnings Call This Week | PairCorr |
| 0.7 | VINC | Vincerx Pharma Common | PairCorr |
| 0.83 | DVAX | Dynavax Technologies | PairCorr |
Moving against Puma Stock
| 0.85 | VCYT | Veracyte | PairCorr |
| 0.8 | OSE | OSE Pharma SA | PairCorr |
| 0.65 | RAC | Race Oncology | PairCorr |
| 0.38 | VCEL | Vericel Corp Ord Downward Rally | PairCorr |
| 0.32 | VANI | Vivani Medical | PairCorr |
| 0.84 | DTIL | Precision BioSciences | PairCorr |
| 0.8 | DRMA | Dermata Therapeutics | PairCorr |
| 0.45 | ABNX | Abionyx Pharma SA Earnings Call This Week | PairCorr |
| 0.39 | DXB | Dimerix | PairCorr |
| 0.85 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.75 | DYAI | Dyadic International | PairCorr |
| 0.71 | IGS1 | India Globalization | PairCorr |
| 0.7 | BIM | Biomerieux SA | PairCorr |
| 0.64 | VKTX | Viking Therapeutics | PairCorr |
| 0.57 | 9OF | BIORESTORATTHERAPDL | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Puma Stock performing well and Puma Biotechnology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Puma Biotechnology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ELDN | 3.31 | 0.86 | 0.24 | 0.59 | 2.88 | 8.97 | 20.18 | |||
| ABEO | 2.41 | 0.12 | 0.05 | 0.17 | 2.65 | 5.34 | 12.04 | |||
| VYGR | 2.61 | (0.10) | (0.02) | 0.01 | 2.95 | 5.59 | 19.71 | |||
| AVIR | 2.23 | 0.71 | 0.27 | 23.41 | 1.73 | 7.21 | 17.79 | |||
| ARCT | 2.60 | 0.31 | 0.13 | 0.25 | 2.61 | 6.65 | 15.98 | |||
| ALLO | 4.66 | 1.25 | 0.25 | 0.69 | 4.13 | 13.43 | 26.97 | |||
| HUMA | 4.29 | (0.11) | (0.01) | 0.02 | 4.75 | 11.11 | 43.72 | |||
| TRDA | 2.59 | 0.21 | 0.07 | 0.27 | 2.91 | 6.40 | 15.20 | |||
| SGMT | 3.15 | (0.25) | 0.00 | (0.12) | 0.00 | 6.08 | 22.02 |
Puma Biotechnology Corporate Management
| Jeffrey Ludwig | Chief Officer | Profile | |
| Roger Storms | Senior Sales | Profile | |
| Alvin Pharmd | Chief Officer | Profile | |
| Heather Blaber | Senior Marketing | Profile | |
| FRAPS BSc | Pharmacovigilance, Affairs | Profile |